PDE4A and chronic obstructive pulmonary disease: Roflumilast (3-cyclo-propylmethoxy-4-difluoromethoxy-N-[3,5-dichloropyrid-4-yl]-benzamide) is a selective PDE4 inhibitor used to control acute exacerbations in patients with severe COPD [3].